Insider transactions

EDGAR

ESSA Pharma Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BIOTECHNOLOGY VALUE FUND L P Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
BVF I GP LLC Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
BIOTECHNOLOGY VALUE FUND II LP Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
BVF II GP LLC Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
Biotechnology Value Trading Fund OS LP Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
BVF Partners OS Ltd. Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
BVF GP HOLDINGS LLC Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
BVF PARTNERS L P/IL Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
BVF INC/IL Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
LAMPERT MARK N Common Shares00.0010/09/2025 Filed 2025-10-14SCHEDULE 13D/AAmendment 2Open filing 0000921895-25-002741 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016682 Dispute this row
KEVIN TANG Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016682 Dispute this row
TANG CAPITAL PARTNERS, LP Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016682 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016682 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016682 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016682 Dispute this row
CONCENTRA BIOSCIENCES, LLC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016682 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016689 Dispute this row
KEVIN TANG Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016689 Dispute this row
TANG CAPITAL PARTNERS, LP Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016689 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016689 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016689 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016689 Dispute this row
CONCENTRA BIOSCIENCES, LLC Common Shares, no par value per share00.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001214659-25-016689 Dispute this row
Morgan Stanley Common Shares4.01,904,06209/30/2025 Filed 2025-10-07SCHEDULE 13G/AAmendment 1Open filing 0000895421-25-000531 Dispute this row
Morgan Stanley Co. LLC Common Shares0.0009/30/2025 Filed 2025-10-07SCHEDULE 13G/AAmendment 1Open filing 0000895421-25-000531 Dispute this row
BIOTECHNOLOGY VALUE FUND L P Common Shares13.16,194,145.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
BVF I GP LLC Common Shares13.16,194,145.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
BIOTECHNOLOGY VALUE FUND II LP Common Shares9.994,726,743.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
BVF II GP LLC Common Shares9.994,726,743.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
Biotechnology Value Trading Fund OS LP Common Shares1.2560,797.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
BVF Partners OS Ltd. Common Shares1.2560,797.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
BVF GP HOLDINGS LLC Common Shares23.110,920,888.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
BVF PARTNERS L P/IL Common Shares24.711,668,473.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
BVF INC/IL Common Shares24.711,668,473.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
LAMPERT MARK N Common Shares24.711,668,473.0008/05/2025 Filed 2025-08-07SCHEDULE 13D/AAmendment 1Open filing 0000921895-25-002132 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Shares, no par value per share9.74,300,000.0007/30/2025 Filed 2025-07-30SCHEDULE 13GOpen filing 0001214659-25-011138 Dispute this row
KEVIN TANG Common Shares, no par value per share9.74,300,000.0007/30/2025 Filed 2025-07-30SCHEDULE 13GOpen filing 0001214659-25-011138 Dispute this row
TANG CAPITAL PARTNERS, LP Common Shares, no par value per share5.52,418,320.0007/30/2025 Filed 2025-07-30SCHEDULE 13GOpen filing 0001214659-25-011138 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Shares, no par value per share4.21,881,680.0007/30/2025 Filed 2025-07-30SCHEDULE 13GOpen filing 0001214659-25-011138 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Shares, no par value per share0.00.0007/30/2025 Filed 2025-07-30SCHEDULE 13GOpen filing 0001214659-25-011138 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Shares, no par value per share0.00.0007/30/2025 Filed 2025-07-30SCHEDULE 13GOpen filing 0001214659-25-011138 Dispute this row
CONCENTRA BIOSCIENCES, LLC Common Shares, no par value per share00.0007/30/2025 Filed 2025-07-30SCHEDULE 13GOpen filing 0001214659-25-011138 Dispute this row
SOLEUS CAPITAL MASTER FUND, L.P. Common Stock9.84,362,026.0007/17/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 2Open filing 0001213900-25-066143 Dispute this row
SOLEUS CAPITAL, LLC Common Stock9.84,362,026.0007/17/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 2Open filing 0001213900-25-066143 Dispute this row
SOLEUS CAPITAL GROUP, LLC Common Stock9.84,362,026.0007/17/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 2Open filing 0001213900-25-066143 Dispute this row
SOLEUS CAPITAL MANAGEMENT, L.P. Common Stock9.84,362,026.0007/17/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 2Open filing 0001213900-25-066143 Dispute this row
SOLEUS GP, LLC Common Stock9.84,362,026.0007/17/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 2Open filing 0001213900-25-066143 Dispute this row
GUY LEVY Common Stock9.84,362,026.0007/17/2025 Filed 2025-07-21SCHEDULE 13D/AAmendment 2Open filing 0001213900-25-066143 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,686,506 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015103,592
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,124

Filings made before the SEC required XML are listed, not extracted.

Back to ESSA Pharma Inc.